An existing anti-seizure drug slows the growth of a devastating group of childhood cancers, new Stanford Medicine-led research has shown. The tumors, called diffuse midline gliomas, strike the brain and spinal cord. They affect 300 to 400 U.S. children per year and have a five-year survival rate of about 1%.
❓ Unknown
Existing Anti-Seizure Drug Shows Promise Against Aggressive Childhood Brain Tumors
Just now
September 17, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
Stanford Medicine research indicates that an existing anti-seizure drug can slow the growth of aggressive childhood brain tumors known as diffuse midline gliomas, which affect hundreds of children annually in the U.S. This finding is significant as it may lead to new treatment options for similar conditions in Iran, where healthcare advancements are crucial.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
18 min ago •
UN Experts Investigate Possible US War Crimes in Iran Strikes
18 min ago •
The Houthis: From Local Militia to Regional Power and Its Implications for Iran
21 min ago •
UN Suggests US Involvement in Iran School Bombing
27 min ago •
New Method for Assessing Aging Could Lead to Faster Anti-Aging Treatments
27 min ago •